Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03593603 · ClinicalTrials.gov registry record

Trending of Respiratory Rate Using the Nellcor™ Bedside Respiratory Patient Monitoring System

A clinical trial of Patients Prescribed Non-invasive Respiratory Monitoring, sponsored by Medtronic - MITG.

Completed
Registry status
37
Enrollment target
2
Study locations

NCT03593603 is a study of Patients Prescribed Non-invasive Respiratory Monitoring that has completed, run by Medtronic - MITG. The registered enrollment target is 37 participants. The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03593603, a study of Patients Prescribed Non-invasive Respiratory Monitoring, has completed, sponsored by Medtronic - MITG.

COMPLETED
Registry status
37 participants
Enrollment target
2
Study locations

Study Summary

This is an open-label, non-randomized, prospective, descriptive study of the Nellcor™ Bedside Respiratory Patient Monitoring System using the Nellcor™ Respiration Rate parameter and Nellcor™ Adult Respiratory Sensor The study is intended to gain further information in the clinical space on the function of the Nellcor™ Respiration Rate parameter. The primary objective is to describe spot check (e.g. manual observation) of respiration rate versus cumulative automated counting (trend) of respiratory rate as measured using the Nellcor™ Bedside Respiratory Patient Monitoring System with the Nellcor™ Respiration Rate parameter.

Interventions

  • DEVICE Nellcor™ Bedside Respiratory Monitoring System

Study Locations (2)

Oklahoma

  • St. John Health System - Tulsa

Washington

  • MultiCare Institute for Research & Innovation - Tacoma

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2018-07-11
Est. Completion 2019-05-03

Sponsor

Medtronic - MITG

119 total trials

What the Registry Record Tells You About NCT03593603

The ClinicalTrials.gov registry entry for NCT03593603 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Patients Prescribed Non-invasive Respiratory Monitoring appearing as the primary indexed condition, and to 1 intervention - of which Nellcor™ Bedside Respiratory Monitoring System is the first listed.

NCT03593603 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Oklahoma, Washington.

Frequently Asked Questions

What is clinical trial NCT03593603 about?

NCT03593603 is a clinical study titled "Trending of Respiratory Rate Using the Nellcor™ Bedside Respiratory Patient Monitoring System". This is an open-label, non-randomized, prospective, descriptive study of the Nellcor™ Bedside Respiratory Patient Monitoring System using the Nellcor™ Respiration Rate parameter and Nellcor™ Adult Respiratory Sensor The study is intended to gain further information in the clinical space on the funct...

What is the current status of trial NCT03593603?

This trial is currently completed. The enrollment target is 37 participants. The study started on 2018-07-11. Estimated completion is 2019-05-03.

What conditions does trial NCT03593603 study?

This clinical trial studies the following conditions: Patients Prescribed Non-invasive Respiratory Monitoring.

What interventions are being tested in trial NCT03593603?

The interventions under investigation include: Nellcor™ Bedside Respiratory Monitoring System (DEVICE).

Who is sponsoring clinical trial NCT03593603?

This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03593603 being conducted?

This trial has 2 study locations across Oklahoma, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.